Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study
Year: 2024
Type: article
Study design: Observational Study
Source: British Journal of Dermatology
DOI: 10.1093/bjd/ljae152
Authors: Keila Mitsunaga, Martine Bagot, Caroline Ram-Wolff, Emmanuella Guenova, Christina von Gugelberg, Emmilia Hodak, Iris Amitay-Laish, Evangelia Papadavid, Constanze Jonak, Stefanie Porkert, Julia Scarisbrick, Rona Applewaite, Marie Beylot-Barry, Jan Nicolay, Pietro Quaglino, José Antonio Sanches, Jade Cury-Martins, David Lora-Pablos, Pablo Ortiz
Institutions: Hospital Universitario 12 De Octubre, Université Paris Cité, Hôpital Saint-Louis, University of Zurich, Centre Hospitalier Universitaire Vaudois, University Hospital Zurich, Tel Aviv University, Rabin Medical Center, National and Kapodistrian University of Athens, University General Hospital Attikon, Medical University of Vienna, University Hospitals Birmingham NHS Foundation Trust, Centre Hospitalier Universitaire de Bordeaux, University Medical Centre Mannheim, University of Turin, Universidade de São Paulo, Research Institute Hospital 12 de Octubre
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4394673692